An 18F-MD-PSMA (Multi-dentate PMSA Imaging Agent) PET/CT in Prostate Cancer Relapse: Results of a Retrospective Trial

CONCLUSION: An 18F-MD-PSMA as a radioligand was found to be superior to 11C-choline in the setting of patients with biochemical relapse after previous treatment. Its PET imaging results matched those of established PSMA radioligands, but its chemical structure was found to have added features to conjugate with other functional molecules, such as those with therapeutic properties. This radioligand lays the foundation for our further work.PMID:37724670 | DOI:10.2174/1874471016666230915103157

Source: Current Radiopharmaceuticals - September 19, 2023 Category: Radiology Authors: HongLiang Fu Sheng Liang MiaoMiao Xu Jun Guo Qiang Liu Jian Kang LinLin Zhang ZiHao Liu Lin Ding YuFei Ma Bin Yang Xudong Yao Jun Qi Hui Wang YongQuan Cai Source Type: research